 Shares of NanoVibronix Inc. more than tripled in very volatile and active afternoon trading Friday, after the company pointed out an upbeat report regarding its treatment for urinary tract infections. The stock was up 204 before the latest volatility trading halt, as volume of 58.8 million shares compared with the full-day average of about 204,000 shares. 